By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OrbusNeich 

5th Floor, Neich Tower
128 Gloucester Road
Wanchai      Hong Kong
Phone: 852-2802-2288 Fax: 852-2507-3532


SEARCH JOBS


Industry
Biotechnology






Company News
OrbusNeich Names B. Wayne Johnson President and Chief Operating Officer and Expands Board of Directors 4/24/2014 6:29:52 AM
OrbusNeich Initiates HARMONEE Study In Japan To Evaluate The COMBO™ Dual Therapy Stent 2/26/2014 11:41:50 AM
OrbusNeich's COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes Out to 24 Months 10/30/2013 10:07:44 AM
Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013 10/22/2013 9:11:34 AM
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent™ in Routine Practice 8/6/2013 10:22:10 AM
OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents 5/28/2013 9:47:57 AM
OrbusNeich Release: Delayed Healing of Coronary Artery Following Implantation of Drug Eluting Stents, Increasing Risk of Thrombosis, is a Top Concern of Interventional Cardiologists, International Survey Shows 5/21/2013 10:03:46 AM
OrbusNeich's Genous™ Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients 5/20/2013 10:15:55 AM
OrbusNeich Release: COMBO Dual Therapy Stent™ Clinical Results to be Featured at EuroPCR 2013 5/13/2013 7:43:55 AM
OrbusNeich Enforces Injunction Against Boston Scientific Corporation (BSX) in Germany 5/7/2013 10:01:51 AM
1234567
//-->